Follicum collaborates with proDERM for the upcoming Phase IIa clinical trial on patients with hair loss
Follicum today announces that the company has signed a collaboration agreement with proDERM for conducting the new clinical trial with a cream-like formulation of FOL-005 to be tested on alopecia patients (patients with hair loss). The company expects to be ready for starting the clinical trial shortly after the turn of the year.Preparations for the clinical trial are ongoing and through the agreement with the German company proDERM the completion of the study has been secured. proDERM specializes in conducting clinical studies with a focus on hair studies and has the necessary